TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Lower esophageal sphincter (LES) pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: incidence of PHN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to prerandomization monthly seizure count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients requiring antiviral treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of the first course of antiviral treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of HCMV disease
Endpoint domain: Adverse events/effects
Primary endpoint: Average costs to implement SBIRT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to normalization of pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to lower blood glucose to 14 mmol/l
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 1-year Kaplan-Meier survival rate
Endpoint domain: Mortality/survival
Primary endpoint: treatment-evoked tooth pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial glycemic rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: recurrent stroke rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: odds of dementia
Endpoint domain: Mortality/survival
Primary endpoint: proportion of patients staying longer than expected
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: proportion experiencing any adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: recurrence-free period
Endpoint domain: Mortality/survival
Primary endpoint: decreased annual locomotor training costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BCVA change at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tinnitus-related distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CA PSV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CA EDV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CA PI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SMA RI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Teacher SNAP ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent SNAP ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Math Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sBP, dBP, and MAP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Rate (HR) measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of sedation-hypnosis, nystagmus, and dizziness
Endpoint domain: Adverse events/effects
Primary endpoint: SF-36 physical component summary
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF-36 bodily pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gastric emptying half-emptying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Blood pressure difference between groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Unilaterality of blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for vasopressors
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Confirmed allergic reactions to food challenges
Endpoint domain: Adverse events/effects
Primary endpoint: patient record completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mortality of An. gambiae
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in restraint use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Port site pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of measurements within blood glucose target range (70 to 180 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ratings of good or excellent after 24 hours of treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vesicoureteral reflux resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: muscle activation strategy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Standard deviation of intervals between heartbeats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High frequency power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: confidence in history-taking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ability to detect depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Circulating FGF-21 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone Mineral Content (BMC) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortical flow reduction after SWL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Severity of obstructive sleep apnea/hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Alanine aminotransferase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: F(2)-isoprostanes levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fatal or non-fatal congestive heart failure (CHF)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in IBS-SSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Male sterility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: subjective assessment of 'different sensation'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area of sensory deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h cumulative urinary glucose excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h mean glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ejaculatory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sexual problem assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: prevalence of sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to stoma proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned stoma-related community interventions per patient
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adjusted mean scores for items recommended for exclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mean scores for other tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of radiographic neurologic injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Need for rescue antiemetic
Endpoint domain: Adverse events/effects
Primary endpoint: Median lowest pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time that pH remained below 5.7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return to resting pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NHPT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AAA size reaching 5 cm in diameter within 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Psychomotor development quotients
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decrease in Ki67
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pap test knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cervical cancer knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-efficacy of recommending the Pap test
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved knowledge about deprescribing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased concern about taking benzodiazepines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased self-efficacy in tapering
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: external rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustaining regular application of sunscreen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pruritus scores after feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal PVAS score after feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal due to pruritus flare
Endpoint domain: Adverse events/effects
Primary endpoint: Mean plasma clearance of intravenous fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pharmacokinetics outcomes
Primary endpoint: Area under the fentanyl plasma concentration-time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pharmacokinetics outcomes
Primary endpoint: Cosmetic result
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of early adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: MEP amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of severe coronary calcification (CACS > 400)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prediction of obstructive CAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in HbA(1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Odds of experiencing a hypoglycaemic event
Endpoint domain: Adverse events/effects
Primary endpoint: Time required to achieve blood pressure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of asthma symptom-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FACIT-Fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean period of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Level of serum CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication of rectal carriage of 3GCR-E
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Eradication of rectal carriage of CR-GNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acquisition of respiratory tract carriage of 3GCR-E
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acquisition of respiratory tract carriage of CR-GNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: menstrual cycle symptom change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression change scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anger or irritability change scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: physical symptoms change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of femoral PLLA-HA screw
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ossification response of femoral and tibial tunnels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in gum bleeding points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in multivitamin intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in red meat consumption
Endpoint domain: Life impact
Endpoint subdomain: Dietary habits
Primary endpoint: elbow extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: shoulder elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total root mean square (RMS) of lower order aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative total RMS of higher order aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of tear trough rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pap test screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tonic craving levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐reported reward from smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: short-term knowledge assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inducible nitric oxide synthase mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orgasm dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Onset of Impairment (TOI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical well-being (PWB)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: time to radiographic fracture healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to cast removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Barrier disruption measured by TEWL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: total spine RVUs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: knee-joint motor function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Arthritis Impact Measurement Scale score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in patient-reported nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral embolization detected by TCD and DW-MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Sensitivity of detecting ulcerated plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of detecting ulcerated plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive predictive value of identifying an ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of STI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PCO score at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective stress urinary incontinence (SUI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean bronchoscopy quality score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pass rate of participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory markers (RANTES, IL-6, IL-1β, IL-8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: decrement of depression level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increment in life satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma levels of glutamine and asparagine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of cervix cancer
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of precursory lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Median operative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required to remove the suction drain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak early diastolic strain rate (SR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in pericardial fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall biliary complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: absolute number of CD4(+), CD8(+), and CD57(+) cells per mm(2) tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: systemic oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for extracorporeal membrane oxygenation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: differentially expressed proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Component removal for any reason or definite radiographic loosening
Endpoint domain: Mortality/survival
Primary endpoint: ΔL:M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPI-SPECT image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C3 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of MEE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement with evidence-based clinical guideline
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Postoperative pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of PVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Liver decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean tolerance scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Predictive validity of behavioural intentions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of diagnoses of medically unexplained physical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RF recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: M1/atazanavir ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: M2/atazanavir ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of successful bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Defecatory desire volumes to rectal balloon distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Wexner constipation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: VMO‐VL timing during stair descent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for cola drink
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ASS at T60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of periprosthetic BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women electing HRT after bone mineral density test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean instrumentation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: serum hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes